Skip to content

API Data Insights

Numbers don’t lie, companies do

  • All News
  • Market Watch
  • Deep Dives
  • Signals
  • Case Files
  • Opinion
  • Exposés
  • Regulatory

Newswire

FDA Approves Generic HIV Prevention Shot by Dr. Reddy’s Laboratories
Newswire

FDA Approves Generic HIV Prevention Shot by Dr. Reddy’s Laboratories

November 3, 2026
After months of anticipation, the Food and Drug Administration gave tentative approval to Dr. Reddy’s…
Sourcing Strategies for API Supply Chain Resilience
Newswire

Sourcing Strategies for API Supply Chain Resilience

November 3, 2026
The pharmaceutical supply chain, which moves drugs from raw materials to patients, begins with Active…
Technology Transfer Essential for Manufacturing Readiness
Newswire

Technology Transfer Essential for Manufacturing Readiness

November 3, 2026
Successful technology transfer involves more than just completing documentation; it requires ensuring that the receiving…
10x Genomics Launches Sentira for Single-Cell Analysis
Newswire

10x Genomics Launches Sentira for Single-Cell Analysis

November 3, 2026
10x Genomics has launched Sentira Single Cell, a cloud-based analysis tool powered by Anthropic’s Claude…
Navigating Complexity in Biologics Development
Newswire

Navigating Complexity in Biologics Development

November 3, 2026
The biologics industry is facing increased complexity as pipelines expand beyond monoclonal antibodies to include…
Keytruda Biosimilars Face Market Challenges
Newswire

Keytruda Biosimilars Face Market Challenges

November 3, 2026
A patent cliff is approaching for Merck’s flagship blockbuster Keytruda, which could open the door…
FDA Delays PDUFA Action on Agios’ Mitapivat sNDA for SCD
Newswire

FDA Delays PDUFA Action on Agios’ Mitapivat sNDA for SCD

November 3, 2026
The FDA has delayed a decision on Agios Pharmaceuticals’ supplemental New Drug Application (sNDA) seeking…
AstraZeneca Restructures, Alnylam Faces Challenges, Regeneron Reports Success
Newswire

AstraZeneca Restructures, Alnylam Faces Challenges, Regeneron Reports Success

November 3, 2026
AstraZeneca is set to redeploy resources as part of a new restructuring program aimed at…
FDA Issues Revised Guidance on Drug Delivery Devices
Newswire

FDA Issues Revised Guidance on Drug Delivery Devices

November 3, 2026
The FDA has announced a revised draft guidance for industry titled “Essential Drug Delivery Performance…
Neuralink’s Blindsight Vision Implant Faces Clinical Readiness Questions
Newswire

Neuralink’s Blindsight Vision Implant Faces Clinical Readiness Questions

November 3, 2026
Neuralink’s plans for a brain implant designed to restore vision have gained attention following a…

About Us

For years we’ve built comprehensive pharmaceutical databases, collecting API, FDF, and excipient suppliers worldwide, with pricing and regulatory details.

Now we present this journal & store: coverage of pharma events, news, and market trends.

Read more →

Contact & Support

Company: API DATA

Location: Israel, Northern District — Gidona

Email: support@api-fdf.com

Connect

Explore our API & FDF Intelligence Database for structured insights on APIs, FDFs, excipients, and compliance worldwide.

Follow updates on LinkedIn.

  • Privacy Policy
  • About Us
  • Home
© API DATA, 2025. All rights reserved Theme: Eternal News By Artify Themes.